Walkner Condon Financial Advisors LLC Danaher Corp Transaction History

Walkner Condon Financial Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	BUY	$224.58 - $256.19 $12,127 - $13,834	54 Added 5.42%	1,051 $262,000
Q4 2023 Jan 23, 2024	BUY	$185.1 - $233.13 $16,844 - $21,214	91 Added 10.04%	997 $230,000
Q3 2023 Oct 19, 2023	BUY	$233.08 - $265.59 $13,052 - $14,873	56 Added 6.59%	906 $224,000
Q2 2023 Jul 21, 2023	BUY	$224.99 - $256.14 $1,799 - $2,049	8 Added 0.95%	850 $204,000
Q1 2023 Apr 20, 2023	SELL	$239.75 - $277.0 $16,063 - $18,559	-67 Reduced 7.37%	842 $212,000

Q4 2022 Jan 25, 2023	BUY	$241.42 - $282.29 $14,726 - $17,219	61 Added 7.19%	909 $0
Q3 2022 Oct 28, 2022	BUY	$247.06 - $1507.4 $6,176 - $37,685	25 Added 3.04%	848 $219,000
Q2 2022 Aug 04, 2022	BUY	$237.11 - $299.66 $195,141 - $246,620	823 New	823 $209,000

2,389

558M

3.53M

3.97M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $199B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Walkner Condon Financial Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Walkner Condon Financial Advisors LLC with notifications on news.